Carlsbad Technology Inc. entered the U.S. generic pharmaceutical market in 1990, beginning as a contract manufacturer of generic pharmaceuticals and has become an industry leader in manufacturing and distribution, with our facilities being granted cGMP validation in 1998. The company’s first ANDA was approved in 1998 for Diclofenac Sodium Delayed Release Tablets. All of Carlsbad Technology Inc.’s procedures comply with the highest Quality Assurance standards, exceeding Current Good Manufacturing Practices (cGMP) as required by Food and Drug Administration (FDA).